Varanasi R, Bardeesy N, Ghahremani M, Petruzzi M J, Nowak N, Adam M A, Grundy P, Shows T B, Pelletier J
Department of Biochemistry, McGill University, Montreal, PQ Canada.
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3554-8. doi: 10.1073/pnas.91.9.3554.
Molecular genetic studies indicate that the etiology of Wilms tumor (WT) is complex, involving at least three loci. Germ-line mutations in the tumor suppressor gene, WT1, have been documented in children with WTs and urogenital developmental anomalies. Sporadic tumors constitute the majority (> 90%) of WT cases and previous molecular analyses of the WT1 gene have focused only on the DNA-binding domain. Using the single-strand conformational polymorphism (SSCP) assay, we analyzed the structural integrity of the entire WT1 gene in 98 sporadic WTs. By PCR-SSCP we find that mutations in the WT1 gene are rare, occurring in only six tumors analyzed. In one sample, two independent intragenic mutations inactivated both WT1 alleles, providing a singular example of two different somatic alterations restricted to the WT1 gene. This case is consistent with the existence of only one tumor suppressor gene at 11p13 involved in the pathogenesis of WTs. Our data, together with the previously ascertained occurrence of large deletions/insertions in WT1, define the frequency at which the WT1 gene is altered in sporadic tumors.
分子遗传学研究表明,肾母细胞瘤(WT)的病因复杂,至少涉及三个基因座。肿瘤抑制基因WT1的种系突变已在患有WT和泌尿生殖系统发育异常的儿童中得到记录。散发性肿瘤占WT病例的大多数(>90%),以往对WT1基因的分子分析仅集中在DNA结合域。我们使用单链构象多态性(SSCP)分析方法,对98例散发性WT中的整个WT1基因的结构完整性进行了分析。通过聚合酶链反应-SSCP(PCR-SSCP),我们发现WT1基因中的突变很少见,仅在分析的6个肿瘤中出现。在一个样本中,两个独立的基因内突变使两个WT1等位基因均失活,这是仅局限于WT1基因的两种不同体细胞改变的唯一实例。该病例与11p13处仅存在一个参与WT发病机制的肿瘤抑制基因的情况一致。我们的数据,连同先前确定的WT1中大片段缺失/插入的发生情况,确定了散发性肿瘤中WT1基因改变的频率。